This is a large, carefully designed observational study not a randomised trial so it points to a promising signal rather than a proven benefit
Once-daily oral semaglutide is the only oral GLP-1 receptor agonist currently available, with the 14 mg dose associated with significant improvements in HbA1c and body weight versus liraglutide 1.8 mg (the highest dose of liraglutide approved for treating type 2 diabetes) after 52 weeks in the PIONEER 4 clinical trial, in people with inadequate glycemic control on metformin with or without a sodium-glucose cotransporter-2 (SGLT-2) inhibitor [11]
10.1186/s12933-025-02862-x 97 Luis-GarcaE
A., Olartecoechea, B., Graupera, B., Auba, M., Ajossa, S., & Guerriero, S
your prescriber submits the PA) What the $50 Doesn't Count Toward (The 3 Catches) The Bridge copay is collected at the pharmacy, but watch for three things: It does not apply to your Part D deductible It does not count toward your annual out-of-pocket cap Extra Help / LIS doesn't reduce it even beneficiaries who normally pay $0$10 pay the full $50 [29] Full Bridge Guide: Eligibility, Cost & How to Apply For the complete BMI tiers and qualifying conditions, plan-type eligibility, the cost catches, and the step-by-step prior authorization process, see our dedicated Medicare GLP-1 Bridge guide
